Asparagine deamidation perturbs antigen presentation on class II major histocompatibility complex molecules

被引：0
|
作者：
Moss, Catherine X. [1 ]
Matthews, Stephen P. [1 ]
Lamont, Douglas J. [2 ]
Watts, Colin [1 ]
机构：
[1] Division of Cell Biology and Immunology, University of Dundee, Dundee DD1 5EH, United Kingdom
[2] School of Life Sciences, University of Dundee, Dundee DD1 5EH, United Kingdom
来源：
J. Biol. Chem. | / 18卷 / 18498-18503期
关键词：
Compendex;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Cells - Diseases - Immunology - Polypeptides
引用
收藏
相关论文
共 50 条
  • [31] Major histocompatibility complex class II-dependent antigen presentation by human intestinal endothelial cells
    Haraldsen, G
    Sollid, LM
    Bakke, O
    Farstad, IN
    Kvale, D
    Molberg, O
    Norstein, J
    Stang, E
    Brandtzaeg, P
    GASTROENTEROLOGY, 1998, 114 (04) : 649 - 656
  • [32] Trypanosoma cruzi-infected macrophages are defective in major histocompatibility complex class II antigen presentation
    La Flamme, AC
    Kahn, SJ
    Rudensky, AY
    Van Voorhis, WC
    EUROPEAN JOURNAL OF IMMUNOLOGY, 1997, 27 (12) : 3085 - 3094
  • [33] Cathepsins B and D are dispensable for major histocompatibility complex class II-mediated antigen presentation
    Deussing, J
    Roth, W
    Saftig, P
    Peters, C
    Ploegh, HL
    Villadangos, JA
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (08) : 4516 - 4521
  • [34] A revised view of the central nervous system microenvironment and major histocompatibility complex class II antigen presentation
    Perry, VH
    JOURNAL OF NEUROIMMUNOLOGY, 1998, 90 (02) : 113 - 121
  • [35] Deficient major histocompatibility complex class II antigen presentation in a subset of Hodgkin's diseasetumor cells
    Bosshart, H
    Jarrett, RF
    BLOOD, 1998, 92 (07) : 2252 - 2259
  • [36] Biologic consequences of defective major histocompatibility complex class II presentation
    Eibl, MM
    Wolf, HM
    ANTIGEN PRESENTATION, 1998, 232 : 217 - 240
  • [37] Peptidomimetic compounds that inhibit antigen presentation by autoimmune disease-associated class II major histocompatibility molecules
    Fiorenza Falcioni
    Kouichi Ito
    Damir Vidovic
    Charles Belunis
    Robert Campbell
    Steven J. Berthel
    David R. Bolin
    Paul B. Gillespie
    Nicholas Huby
    Gary L. Olson
    Ramakanth Sarabu
    Jeanmarie Guenot
    Vincent Madison
    Jürgen Hammer
    Francesco Sinigaglia
    Michael Steinmetz
    Zoltan A. Nagy
    Nature Biotechnology, 1999, 17 : 562 - 567
  • [38] Enhanced germinal center reaction by targeting vaccine antigen to major histocompatibility complex class II molecules
    Andersen, Tor Kristian
    Huszthy, Peter C.
    Gopalakrishnan, Ramakrishna P.
    Jacobsen, Johanne T.
    Fauskanger, Marte
    Tveita, Anders A.
    Grodeland, Gunnveig
    Bogen, Bjarne
    NPJ VACCINES, 2019, 4 (1)
  • [39] Peptidomimetic compounds that inhibit antigen presentation by autoimmune disease-associated class II major histocompatibility molecules
    Falcioni, F
    Ito, K
    Vidovic, D
    Belunis, C
    Campbell, R
    Berthel, SJ
    Bolin, DR
    Gillespie, PB
    Huby, N
    Olson, GL
    Sarabu, R
    Guenot, J
    Madison, V
    Hammer, J
    Sinigaglia, F
    Steinmetz, M
    Nagy, ZA
    NATURE BIOTECHNOLOGY, 1999, 17 (06) : 562 - 567
  • [40] Enhanced germinal center reaction by targeting vaccine antigen to major histocompatibility complex class II molecules
    Tor Kristian Andersen
    Peter C. Huszthy
    Ramakrishna P. Gopalakrishnan
    Johanne T. Jacobsen
    Marte Fauskanger
    Anders A. Tveita
    Gunnveig Grødeland
    Bjarne Bogen
    npj Vaccines, 4
12345